Top compounds associated with response to RP13-210D15.9


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
mRNA JW-480 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA UNC0638 CTRPv2 pan-cancer AAC -0.042 0.2
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.13 0.2
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.063 0.3
mRNA erismodegib CTRPv2 pan-cancer AAC -0.042 0.3
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.052 0.3
mRNA SR8278 CTRPv2 pan-cancer AAC -0.14 0.3
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA KHS101 CTRPv2 pan-cancer AAC 0.041 0.3
Download CSV